4//SEC Filing
Stewart Murray 4
Accession 0001104659-21-024413
CIK 0001649904other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:27 PM ET
Size
8.1 KB
Accession
0001104659-21-024413
Insider Transaction Report
Form 4
Stewart Murray
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2021-02-11+9,375→ 9,375 total→ Common Stock (9,375 underlying) - Award
Stock Option (Right to Buy)
2021-02-11+56,250→ 56,250 totalExercise: $30.66Exp: 2031-02-10→ Common Stock (56,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date
- [F3]The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001723450
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:27 PM ET
- Size
- 8.1 KB